734 related articles for article (PubMed ID: 29959312)
1. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.
He H; Jiang H; Chen Y; Ye J; Wang A; Wang C; Liu Q; Liang G; Deng X; Jiang W; Zhou R
Nat Commun; 2018 Jun; 9(1):2550. PubMed ID: 29959312
[TBL] [Abstract][Full Text] [Related]
2. NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.
Liu H; Gu C; Liu M; Liu G; Wang Y
Biochem Pharmacol; 2020 Jul; 177():113998. PubMed ID: 32353421
[TBL] [Abstract][Full Text] [Related]
3. Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity.
Zhang X; Hu L; Xu S; Ye C; Chen A
Front Immunol; 2021; 12():739953. PubMed ID: 34745110
[TBL] [Abstract][Full Text] [Related]
4. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation.
Li M; Zhang Y; Qiu S; Zhuang W; Jiang W; Wang C; Zhang S; Zhou Z; Sun T; Ke Z; Guo W; Qiao Y; Shi X
Int Immunopharmacol; 2021 Jun; 95():107576. PubMed ID: 33770730
[TBL] [Abstract][Full Text] [Related]
5. Oridonin ameliorates insulin resistance partially through inhibition of inflammatory response in rats subjected to chronic unpredictable mild stress.
Liang L; Zheng Y; Xie Y; Xiao L; Wang G
Int Immunopharmacol; 2021 Feb; 91():107298. PubMed ID: 33388733
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insight into the attenuation of gouty inflammation by Taiwanese green propolis via inhibition of the NLRP3 inflammasome.
Hsieh CY; Li LH; Rao YK; Ju TC; Nai YS; Chen YW; Hua KF
J Cell Physiol; 2019 Apr; 234(4):4081-4094. PubMed ID: 30370562
[TBL] [Abstract][Full Text] [Related]
8. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.
Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B
EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
Kim SK; Choe JY; Park KY
Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
[TBL] [Abstract][Full Text] [Related]
10. Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity.
He C; Liu J; Li J; Wu H; Jiao C; Ze X; Xu S; Zhu Z; Guo W; Xu J; Yao H
J Med Chem; 2024 Jun; 67(11):9406-9430. PubMed ID: 38751194
[TBL] [Abstract][Full Text] [Related]
11. Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway.
Du X; Que W; Hu X; Yu X; Guo WZ; Zhang S; Li XK
Front Immunol; 2021; 12():719574. PubMed ID: 34566976
[TBL] [Abstract][Full Text] [Related]
12. Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in mice.
Yang H; Huang J; Gao Y; Wen Z; Peng L; Ci X
Inflammopharmacology; 2020 Apr; 28(2):513-523. PubMed ID: 31552548
[TBL] [Abstract][Full Text] [Related]
13. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
[TBL] [Abstract][Full Text] [Related]
14. The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases.
Qin Q; Liu H; Shou J; Jiang Y; Yu H; Wang X
Cell Mol Immunol; 2021 Apr; 18(4):992-1004. PubMed ID: 32901127
[TBL] [Abstract][Full Text] [Related]
15. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination.
Chen H; Lin H; Xie S; Huang B; Qian Y; Chen K; Niu Y; Shen HM; Cai J; Li P; Leng J; Yang H; Xia D; Wu Y
Toxicol Appl Pharmacol; 2019 Feb; 365():19-29. PubMed ID: 30594691
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of oridonin against cerebral ischemia/reperfusion injury by inhibiting the NLRP3 inflammasome activation.
Jia Y; Tong Y; Min L; Li Y; Cheng Y
Tissue Cell; 2021 Aug; 71():101514. PubMed ID: 33676236
[TBL] [Abstract][Full Text] [Related]
17. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
Jiang H; He H; Chen Y; Huang W; Cheng J; Ye J; Wang A; Tao J; Wang C; Liu Q; Jin T; Jiang W; Deng X; Zhou R
J Exp Med; 2017 Nov; 214(11):3219-3238. PubMed ID: 29021150
[TBL] [Abstract][Full Text] [Related]
18. HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction.
Cheng Z; Huang M; Li W; Hou L; Jin L; Fan Q; Zhang L; Li C; Zeng L; Yang C; Liang B; Li F; Chen C
Cell Death Dis; 2024 Jan; 15(1):86. PubMed ID: 38267403
[TBL] [Abstract][Full Text] [Related]
19. Juniperus rigida Sieb. extract inhibits inflammatory responses via attenuation of TRIF-dependent signaling and inflammasome activation.
Han JW; Shim DW; Shin WY; Kim MK; Shim EJ; Sun X; Koppula S; Kim TJ; Kang TB; Lee KH
J Ethnopharmacol; 2016 Aug; 190():91-9. PubMed ID: 27260408
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages.
Shi Y; Lv Q; Zheng M; Sun H; Shi F
Int Immunopharmacol; 2021 Mar; 92():107358. PubMed ID: 33508701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
